As the world watches to see whether President Trump accepts the US election results, few have noticed thatcivil war is looming in Ethiopia, after Prime Minister Abiy Ahmed announced that he was sending troops to the Tigray province. This imperils not only Africa’s second most populous state but its neighbours, Sudan and South Sudan, as well.
Sudan has had a good run recently and is in a better position to weather any regional conflict. In a surprise movelast month, President Trump announced Sudan’s removal from the US State Sponsors of Terrorism List (SST)in exchange for normalising relations with Israel. The US is understood to have sweetened the deal with a raft of economic and political incentives, including humanitarian assistance and high-level trade delegations. It would also support Sudan in its discussions with international finance institutions on economic and debt relief.
Since the toppling of President Bashir in 2019, the new transitional government, led by Prime Minister Hamdok, has focused on reviving Sudan’s economy and managing its $60bn debt burden. Hamdok faces a severe economic crisis, aggravated by the Covid-19 pandemic, high inflation and the worst flooding in decades, that has affected more than 800,000 people and destroyed homes and large tracts of farmland just before the harvest. Food, bread and medicine are in short supply.
Thesanctions removal means that Sudan can now expect substantial assistance from the International Monetary Fund and the World Bankand unlock investment into its fledgling economy.
This is good news for Sudan. But where does it leave its neighbour, South Sudan?
The international community had high hopes for South Sudan when it announced independence in 2011. But its optimism was misplaced. It never understood the Sudanese conflict that began with British colonialism and erupted after the British left in 1956. It wasn’t just a war between the Government of Sudan and the southern Sudanese rebels. Nor was it a fight between the Islamic North and the Christian South. It was a fight over resources and power.
South Sudan continues to fight. After its first post-independence civil war in 2013 and its endless cycle of violence and retribution, South Sudan is now as unstable as it was before it seceded from Sudan. To accommodate the different factions and keep old military men in power, the South Sudanese government and bureaucracy is peopled with those loyal to the former rebels.
Few have the skills needed to manage the country properly. They have squandered their oil opportunity, through mismanagement and corruption. With falling oil growth demand, oil is unlikely to remaina sustainable revenue source. This will challenge the South Sudanese economy which is 90% reliant on oil.
South Sudan is also facing multiple sanctions. In 2014, the international communityimposed travel bans and asset freezes, as well as an arms embargo. In 2018, the EU designated sanctions against individuals involved in serious human rights violations, alarmed by “the outbreak of a destructive conflict between the Government of South Sudan and opposition forces in December 2013.” Most recently, the US added First Vice President of South Sudan, Taban Deng Gai to its Global Magnitsky sanctions list for his involvement in the disappearance and deaths of human rights lawyer Samuel Dong Luak and SPLM-IO member Aggrey Idry.
If US foreign policy towards Sudan was driven by religious and ideological interests in the 1990s and 2000s, what we are now seeing is a shift to transactional diplomacy. There is no reason to think that President Biden would change course.
South Sudan is watching closely. It may be why it has instructed a US lobbying firm to allegedly lobby for their own sanctions removal. It is also why it welcomed a peace deal between Sudan and five rebel groups in September, paving the way for increased oil export cooperation with its neighbour.
But stability in the youngest African state is fragile. Even with a recently signed peace agreement between former foes, President Kiir and Vice-President Machar, violence is always lurking. South Sudan is plagued with the same environmental challenges of flooding and poor harvests. The fighting in Ethiopia will not help.
As South Sudan looks to the North, it will see a New Sudan, unshackled by the weight of its history and benefitting from international goodwill. Will this encourage South Sudan to look forward instead of back? Or will it unleash demons from the past?
Let’s hope that the international community pulls itself away from Trump’s horror show and starts paying attention to East Africa. It may be a long winter.
African Union’s Inaction on Ethiopia Deplorable – Open Letter
A group of African intellectuals says in an open letter that it is appalled and dismayed by the steadily deteriorating situation in Ethiopia. The letter, signed by 58 people, says the African Union’s lack of effective engagement in the crisis is deplorable. The letter calls on regional bloc IGAD and the AU to “proactively take up their mandates with respect to providing mediation for the protagonists to this conflict”.
The letter also asks for “all possible political support” for the AU’s Special Envoy for the Horn of Africa, Olusegun Obasanjo, whose appointment was announced on August 26, 2021. A United Nations Security Council meeting on the same day welcomed the former Nigerian president’s appointment.
Earlier in August 2021, UN chief Antonio Guterres appealed for a ceasefire, unrestricted aid access and an Ethiopian-led political dialogue. He told the council these steps were essential to preserve Ethiopia’s unity and the stability of the region and to ease the humanitarian crisis. He said that he had been in close contact with Ethiopian Prime Minister Abiy Ahmed and had received a letter from the leader of the Tigray region in response to his appeal. “The UN is ready to work together with the African Union and other key partners to support such a dialogue,” he said.
August 26, 2021 was only the second time during the conflict that the council held a public meeting to discuss the situation. Britain, Estonia, France, Ireland, Norway and the United States requested the session.
Fighting between the national government and the Tigray People’s Liberation Front broke out in November 2020, leaving millions facing emergency or crisis levels of food insecurity, according to the United Nations. Both sides have been accused of atrocities.
Africa: The G20 Must Recommit to Covax
It is one year since the international community gave its backing to the COVID-19 Vaccine Global Access (COVAX) facility to lead a worldwide effort to end the acute phase of the pandemic. The initiative aimed to ensure that every country, and not just those with sufficient money or resources, could access life-saving vaccines once they became available. As G20 health ministers prepare to meet in Rome on September 5-6, they are in a position to ensure that COVAX fulfills its mission.
A year ago, no one knew when or even if it might be possible to develop a safe and effective vaccine against COVID-19, let alone the 20 that are available today. But since making its first international deliveries in February, COVAX a partnership established by the Coalition for Epidemic Preparedness Innovations, the World Health Organization, UNICEF, and Gavi, the Vaccine Alliance has delivered more than 235 million vaccine doses to 139 countries, and expects to deliver another billion doses in the fourth quarter. Only China, India, and the United States have delivered more. This start to the largest and most complex vaccine rollout in history has given hope to millions of people and laid solid foundations for how we respond to future pandemics.
Yet, so much more could, and should, have been achieved by now. It is unacceptable that only 1.8% of people in low-income countries have received their first dose of a COVID-19 vaccine, compared to 82% in high- and upper-middle-income countries. This shocking inequality is as economically senseless as it is destructive to human life, with the latest estimate of the cost of the slow rollout amounting to $2.3 trillion.
The world was woefully unprepared for a pandemic, and this is reflected in the challenges COVAX has faced. By the time initial funding arrived, wealthy countries had already locked up early vaccine supplies. Export bans affecting key suppliers, and difficulties experienced by many manufacturers in scaling up production to the required level, also undermined COVAX’s ability to access doses early.
Given increasing global vaccine inequity and the rise of new, more contagious coronavirus variants, we must put these challenges behind us. Thanks to the support of almost all G20 governments, alongside that of foundations and private businesses, COVAX has now raised nearly $10 billion and secured more than 600 million donated doses. All the preparations are in place for the most comprehensive vaccination effort that the world has seen.
Based on the committed orders COVAX has placed with vaccine manufacturers and the additional donations, hundreds of millions of new doses should now be available each month. We need to make sure they reach poorer countries and get into people’s arms. To avoid further delays, and for the facility to succeed, we need support from G20 leaders in four key areas.
First, we need doses, and we need them now. The premise of COVAX was always that the facility should be able to negotiate and buy its own doses. With our early vaccine access compromised, donations have played a vital role in maintaining our ability to keep doses flowing to those most in need. Of the 600 million doses pledged to COVAX to date, 100 million have now been delivered. We need more, and soon, with longer shelf lives and greater certainty so that recipient countries have time to plan their rollout. This can be achieved without jeopardizing high-income countries’ national vaccination efforts.
We also need G20 leaders to support our call for transparency. COVAX has legally binding agreements with manufacturers for more than four billion doses, but has all too often faced delays in accessing them. Without greater clarity regarding firms’ order books, it is impossible to know whether these holdups are due to production challenges or preferential treatment for bilateral arrangements. Insisting that manufacturers are transparent about their order timelines can ensure a level playing field where no one particularly those living in developing countries gets bumped to the back of the vaccine queue because of another bilateral deal.
In addition to ensuring that manufacturers keep their commitment to COVAX, governments should make global vaccine access their highest priority. Countries with pending orders for doses that they currently do not need should allow COVAX to take their place in the queue so that we can get doses to needy countries now.
Finally, lower-income countries require continued financial and technical support for their COVID-19 vaccine rollouts. Strengthening national health systems will help these countries to ensure delivery of doses and mitigate the pandemic’s secondary effects, and will leave in place infrastructure critical to future global health security.
By recommitting to COVAX, G20 leaders will recommit to a multilateral solution that builds on the astounding scientific progress of the past year. Based on COVAX’s latest forthcoming supply forecast, when topped up with doses through bilateral deals, equitable COVID-19 vaccine access can protect up to 60% of the adult population in 91 lower-income countries. This would represent a huge step toward the WHO target of 70%, which is needed to suppress the coronavirus everywhere, and COVAX represents the best opportunity to achieve it.
Failure would mean more lives lost, broken health-care systems, even deadlier and more transmissible variants, and a pandemic with no end in sight. The G20 must not allow that to be an option.
More African Countries Register Russia’s Sputnik Vaccine
Africa Centres for Disease Control and Prevention (Africa CDC) is a specialized technical institution of the African Union (AU) that strengthens the capacity and capability of Africa’s public health institutions as well as partnerships to detect and respond quickly and effectively to disease threats and outbreaks, based on data-driven interventions and programmes.
During the outbreak of the coronavirus, the African Vaccine Acquisition Task Team (AVATT), was established by African Union, as a component in support of the Africa Vaccine Strategy and was endorsed by the AU Bureau of Heads of State and Government on 20th of August 2020.
Dr John Nkengasong, Director of the Africa Centers for Disease Control and Prevention (Africa CDC), has emphasized: “Africa has to team up with development partners to achieve its 60% continent-wide vaccination in the next two years. I think that is why we should as a collective of the continent, and of course, in partnership with the developed world make sure that Africa has a timely access to vaccines to meet our vaccination targets.”
An official media release in February 2021, the Africa Vaccine Acquisition Task Team from the African Union (AU) informed that Russia would supply and deliver 300 million Sputnik V vaccines to Africa. That step was intended to support African countries to attain their targeted immunization of 60% of the population by the year-end. That vaccine story disappeared, but instead what become so common is the speedy registration of Sputnik V on bilateral basis in various African countries.
According to the latest, Nigeria has become the 68th country in the world to approve the Russian vaccine. The use of the Sputnik V coronavirus vaccine has been approved in Nigeria, the Russian Direct Investment Fund (RDIF) said in an official statement.
“The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian Sputnik V vaccine against coronavirus by the National Agency for Food and Drug Administration and Control of Nigeria (NAFDAC). Nigeria has become the 68th country in the world to approve the Russian vaccine. Total population of all countries, where Sputnik V is approved for use, now exceeds 3.7 billion people, which is nearly half of the global population,” the statement said.
“Nigeria is the most populous nation in Africa, and the approval of Sputnik V will provide for using one of the safest and most effective vaccines in the world. Sputnik V is based on a proven human adenoviral vectors platform and is successfully used in over 50 countries. Approval in Nigeria will make an important contribution to the country’s fight against the pandemic,” CEO of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said.
Besides Nigeria, other African countries have registered Russia’s Sputnik V vaccine. Reportedly, the vaccine has been registered in Algeria, Angola, Djibouti, Egypt, Gabon, Ghana, Guinea, Kenya, Morocco, Namibia, Tunisia, the Republic of Congo (DRC) and Zimbabwe.
Russia’s drive to share Sputnik V vaccine, of course, offers a chance to raise its image and strengthen alliances in Africa. Ministry of Foreign Affairs of the Russian Federation has made efforts promoting the vaccine using all its channels. But supply and delivery have largely lagged behind, the pledges have simply not been fulfilled. Russian authorities have oftentimes said that they would step up efforts for fruitful cooperation in combating coronavirus in Africa.
Promising more than can be delivered appears to be a universal problem with coronavirus vaccines, and it is a real risk for Russia as well, said Theresa Fallon, Director of the Brussels-based Centre for Russia Europe Asia Studies. “They have won the gold medal for creating this very effective vaccine,” she said. “But the problem is how are they going to implement production and delivery?”
Russian Direct Investment Fund (RDIF), with profit motivation, has attempted supplying the Russian vaccines through, Sheikh Ahmed Dalmook Al Maktoum, from the Monarch family and a third party in Dubai, United Arab Emirates, to a number of African countries. For instance, the Republic of Ghana reportedly signed US$64.6 million contract for Sputnik V vaccine from Russia through Sheikh Ahmed Dalmook Al Maktoum. It was double the price from the producer as reported in the media.
On the other hand, Russian President Vladimir Putin has noted, in a speech early September, that advanced countries that produce vaccines against the coronavirus do little to protect humanity from the pandemic.
“The benefits of vaccination are enjoyed mostly by advanced economies. The bulk of the vaccines is made there, and it is used to protect their own population. But very little is being done to protect humanity in the broad sense,” Putin said at the plenary session of the Eastern Economic Forum in Vladivostok, the Far East of Russia. “This is very bad for the producers, because all this boomerangs around the globe. For instance, in Africa the level of protection with vaccines is minimal, but contacts with the African countries continue. There is no getting away from this. This infection will return again and again.”
According to an official release obtained late February, the Sputnik V vaccine the following advantages:
• Efficacy of Sputnik V is 91.6% as confirmed by the data published in the Lancet, one of the world’s oldest and most respected medical journals; It is one of only three vaccines in the world with efficacy of over 90%; Sputnik V provides full protection against severe cases of COVID-19.
• The Sputnik V vaccine is based on a proven and well-studied platform of human adenoviral vectors, which cause the common cold and have been around for thousands of years.
• Sputnik V uses two different vectors for the two shots in a course of vaccination, providing immunity with a longer duration than vaccines using the same delivery mechanism for both shots.
• The safety, efficacy and lack of negative long-term effects of adenoviral vaccines have been proven by more than 250 clinical studies over two decades.
• The developers of the Sputnik V vaccine are working collaboratively with AstraZeneca on a joint clinical trial to improve the efficacy of AstraZeneca vaccine.
• There are no strong allergies caused by Sputnik V.
• The price of Sputnik V is less than $10 per shot, making it affordable around the world.
In February, peer-reviewed medical journal The Lancet published an analysis from Phase III clinical trial of the Russian vaccine, showing its 91.6-percent efficacy against symptomatic COVID-19. The Sputnik V vaccine was developed by the Gamaleya Research Institute of Epidemiology and Microbiology.
Sputnik V was registered in Russia on August 11, 2020 as the world’s first officially registered coronavirus vaccine. Russian vaccines have advantages as no deaths have been reported after vaccination with the Sputnik V, Alexander Gintsburg, Director of the Gamaleya Center, the vaccine developer, said and was reported by TASS News Agency. “As of today, no deaths after vaccination with Sputnik V have been registered,” he said.
Russian Direct Investment Fund (RDIF) is Russia’s sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy. RDIF’s management is based in Moscow.
In Africa, during first of September, the coronavirus-related death toll has topped 196,190, while more than 6.9 million recoveries have been reported. South Africa accounts for a majority of coronavirus cases and deaths across Africa – 2,777,659 and 82,261 respectively. The death toll in Tunisia climbed to 23,451, and 664,034 cases have been confirmed. Egypt recorded 16,736 deaths and 288,441 coronavirus cases.
In Sub-Saharan Africa, Ethiopia is ranked second to South Africa (308,134 cases and 4,675 deaths) and is followed by Kenya (235,863 cases and 4,726 deaths) and Nigeria (191,805 and 2,455). The total number of COVID-19 cases has reached almost 8 million in Africa, according to the World Health Organization’s (WHO) Regional Office for Africa.
A Glimpse at China’s Nuclear Build-Up
The People’s Republic of China is now the second largest military spender after the United States, and the country has...
Better Targeting of Social Protection Programs can Significantly Reduce Poverty in Bangladesh
Social Protection Programs remain central to Bangladesh’s sustainable development policy and are progressively benefitting the poorer households. By improving targeting...
Was Trump better for the world than Biden, after all?
Joe Biden and the State Department just approved a major deal with the Saudis for 500mln in choppers maintanance. Effectively,...
Eritrea: Release journalists and politicians arrested 20 years ago
The Eritrean authorities must immediately and unconditionally release 21 journalists and politicians who were arrested in a sweeping crackdown on...
Torture, killings, lawlessness, still blight Burundi’s rights record
The people of Burundi continue to endure serious human rights violations including possible crimes against humanity, the majority committed by...
Appliance standards and labelling is highly effective at reducing energy use
Policies that introduce minimum efficiency performance standards and energy-consumption labelling on appliances and equipment have led to reduced power consumption,...
Women in Albania to Gain Greater Access to Global Digital Jobs Market
“Digital Jobs Albania” is a new World Bank initiative that will help women in Albania gain better access to online...
South Asia4 days ago
Afghanistan: Hazaras in danger of extinction
Economy3 days ago
The Economic Conundrum of Pakistan
Finance4 days ago
2021 China-ASEAN Trade and Economic Cooperation Forum
South Asia4 days ago
Why the Taliban Had to Change
Americas3 days ago
China And U.S. Are On the Brink of War
Africa4 days ago
African Union’s Inaction on Ethiopia Deplorable – Open Letter
Americas3 days ago
20 years after 9/11: American decline in the Islamic world and China- Russian emergence
Central Asia4 days ago
The Effectiveness of Confucius Institutes in Promoting Chinese Soft Power in Kazakhstan